THC Stock Analysis — Tenet Healthcare
Sector: Healthcare
AI Verdict
THC trades at 12.2x next year's earnings with 24.2% growth expected, making it cheap for the growth you're getting if its hospital network can deliver on those forecasts.
Competitive Moat
Tenet Healthcare operates a large network of hospitals and outpatient centers, benefiting from scale-driven cost advantages and local market density that create barriers for new entrants. Its integrated care delivery and managed service agreements with physician groups help lock in patient referrals and insurance contracts.
Summary
THC is trading at a steep discount to healthcare peers despite analyst expectations for 24.2% EPS growth next year.
Where It Stands
The stock trades at 12.2x forward earnings, well below the healthcare sector median of 22x, with 24.2% forward EPS growth and a trailing P/E of 15.2x.
Key Metrics
- Trailing P/E: 15.2x
- Forward P/E: 12.2x
- PEG Ratio: 0.63
- Earnings Growth: +0.2%
- Revenue Growth: +0.1%
- 52-Week High: $283.05
- 52-Week Low: $157.58
Analyst Consensus
23 Buy · 4 Hold · 0 Sell (27 analysts)
Bull Case
With a forward P/E of 12.2x and 24.2% expected EPS growth, THC is cheap for the growth on offer compared to sector norms.
Bear Case
If the forward P/E rerates up to the sector median of 22x, the stock could see a sharp rally, but if growth disappoints, a drop back to the trailing P/E of 15.2x would erase much of the upside.
Catalyst to Watch
Watch for quarterly earnings — any miss on the 24.2% EPS growth expectation could quickly close the valuation gap.